{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:29:32Z","timestamp":1782332972396,"version":"3.54.5"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022kf1190"],"award-info":[{"award-number":["2042022kf1190"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1002801"],"award-info":[{"award-number":["2022YFF1002801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2050"],"award-info":[{"award-number":["824B2050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82450105"],"award-info":[{"award-number":["82450105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071442"],"award-info":[{"award-number":["32071442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011798","name":"Ministry of Agriculture and Rural Affairs of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","award":["TFJC2018005"],"award-info":[{"award-number":["TFJC2018005"]}],"id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cellin.2024.100226","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T12:01:03Z","timestamp":1735041663000},"page":"100226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Precision epitope editing: A path to advanced immunotherapies"],"prefix":"10.1016","volume":"4","author":[{"given":"Rui-Jin","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-0230","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2024.100226_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41551-023-01073-7","article-title":"Enhancement of the viability of T cells electroporated with DNA via osmotic dampening of the DNA-sensing cGAS-STING pathway","volume":"8","author":"An","year":"2024","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.cellin.2024.100226_bib3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.cellin.2024.100226_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102713","article-title":"The black hole: CAR T cell therapy in AML","volume":"15","author":"Atilla","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.cellin.2024.100226_bib6","doi-asserted-by":"crossref","first-page":"11978","DOI":"10.1073\/pnas.1819992116","article-title":"Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies","volume":"116","author":"Borot","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.cellin.2024.100226_bib7","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/MCB.23.12.4199-4206.2003","article-title":"CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice","volume":"23","author":"Brinkman-Van Der Linden","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.cellin.2024.100226_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.celrep.2014.06.038","article-title":"Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody","volume":"8","author":"Broughton","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/j.cellin.2024.100226_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-023-06496-5","article-title":"Epitope editing enables targeted immunotherapy of acute myeloid leukaemia","volume":"621","author":"Casirati","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/annonc\/mdv623","article-title":"Management of immune checkpoint blockade dysimmune toxicities: A collaborative position paper","volume":"27","author":"Champiat","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.cellin.2024.100226_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/j.cellin.2024.100226_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","article-title":"Engineering a precise adenine base editor with minimal bystander editing","volume":"19","author":"Chen","year":"2023","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.cellin.2024.100226_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T cells in recurrent glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 family of cytokines: Regulators of inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cellin.2024.100226_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","article-title":"Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice","volume":"7","author":"Everette","year":"2023","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.cellin.2024.100226_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.cellin.2024.100226_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/crispr.2021.0080","article-title":"Genomic and transcriptomic analyses of prime editing guide RNA-independent off-target effects by prime editors","volume":"5","author":"Gao","year":"2022","journal-title":"CRISPR Journal"},{"key":"10.1016\/j.cellin.2024.100226_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-024-07456-3","article-title":"Selective haematological cancer eradication with preserved haematopoiesis","volume":"630","author":"Garaud\u00e9","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib20","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.cellin.2024.100226_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.cellin.2024.100226_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","article-title":"Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors","volume":"569","author":"Gr\u00fcnewald","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.stem.2023.10.007","article-title":"Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs","volume":"30","author":"Han","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib27","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/s41467-020-17175-8","article-title":"Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma","volume":"11","author":"Hegde","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2024.100226_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: A critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.cellin.2024.100226_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of homologous recombination in eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Annual Review of Genetics"},{"key":"10.1016\/j.cellin.2024.100226_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.cellin.2024.100226_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020200","article-title":"Chimeric antigen receptor (CAR) T cell therapy in acute myeloid leukemia (AML)","volume":"8","author":"Hofmann","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41375-018-0277-8","article-title":"Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR\/Cas9-deletion of CD33 exon 2","volume":"33","author":"Humbert","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.cellin.2024.100226_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.stem.2024.09.003","article-title":"Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia","volume":"31","author":"Ji","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annual Review of Biophysics"},{"key":"10.1016\/j.cellin.2024.100226_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.aaw7166","article-title":"Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice","volume":"364","author":"Jin","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cellin.2024.100226_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cellin.2024.100226_bib38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cell.2018.05.013","article-title":"Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-024-07800-7","article-title":"A\u00a0roadmap for affordable genetic medicines","volume":"634","author":"Kliegman","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Science Advances"},{"key":"10.1016\/j.cellin.2024.100226_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: Emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.cellin.2024.100226_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/73208","article-title":"Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease","volume":"6","author":"Kung","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: Design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib46","article-title":"Rapid generation of long, chemically modified pegRNAs for prime editing","author":"Lei","year":"2024","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.cellin.2024.100226_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12915-020-00849-6","article-title":"Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions","volume":"18","author":"Liu","year":"2020","journal-title":"BMC Biology"},{"key":"10.1016\/j.cellin.2024.100226_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100146","article-title":"PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib49","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib50","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.cellin.2024.100226_bib51","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231235","article-title":"Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy","volume":"220","author":"Marone","year":"2023","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib52","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.cell.2023.03.035","article-title":"Massively parallel base editing to map variant effects in human hematopoiesis","volume":"186","author":"Martin-Rufino","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib53","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.aau8694","article-title":"Immunity as a continuum of archetypes","volume":"364","author":"Mujal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cellin.2024.100226_bib55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-based genome editing through the lens of DNA repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Molecular Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2024.100226_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib58","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","article-title":"Chromatin remodeling at DNA double-strand breaks","volume":"152","author":"Price","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100067","article-title":"Current advances of CRISPR-Cas technology in cell therapy","volume":"1","author":"Qiu","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/d41573-022-00095-1","article-title":"Landscape of cancer cell therapies: Trends and real-world data","volume":"21","author":"Saez-Iba\u00f1ez","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.cellin.2024.100226_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101277","article-title":"New targets for CAR T therapy in hematologic malignancies","volume":"34","author":"Savani","year":"2021","journal-title":"Best Practice & Research Clinical Haematology"},{"key":"10.1016\/j.cellin.2024.100226_bib62","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib63","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41417-021-00418-1","article-title":"Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: A review study","volume":"29","author":"Sheykhhasan","year":"2022","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.cellin.2024.100226_bib64","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.molcel.2022.09.032","article-title":"DNA topology regulates PAM-Cas9 interaction and DNA unwinding to enable near-PAMless cleavage by thermophilic Cas9","volume":"82","author":"Shi","year":"2022","journal-title":"Molecular Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib65","first-page":"78","article-title":"Critical care management of chimeric antigen receptor T-cell therapy recipients","volume":"72","author":"Shimabukuro-Vornhagen","year":"2022","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.cellin.2024.100226_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-024-01233-3","article-title":"Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells","author":"Sousa","year":"2024","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.cellin.2024.100226_bib67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2050-7771-2-4","article-title":"CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies","volume":"2","author":"Testa","year":"2014","journal-title":"Biomarker research"},{"key":"10.1016\/j.cellin.2024.100226_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody-drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.cellin.2024.100226_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100056","article-title":"mRNA produced by VSW-3 RNAP has high-level translation efficiency with low inflammatory stimulation","volume":"1","author":"Wang","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","article-title":"Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.cellin.2024.100226_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100015","article-title":"Current therapy and development of therapeutic agents for lung cancer","volume":"1","author":"Wang","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nbt.4198","article-title":"Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion","volume":"36","author":"Wang","year":"2018","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.cellin.2024.100226_bib73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/mt.2014.164","article-title":"Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia","volume":"23","author":"Wang","year":"2015","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.cellin.2024.100226_bib74","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib75","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41556-021-00671-4","article-title":"Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations","volume":"23","author":"Wang","year":"2021","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.cellin.2024.100226_bib76","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3389\/fimmu.2018.02486","article-title":"Expanding the therapeutic window for CAR T cell therapy in solid tumors: The knowns and unknowns of CAR T cell biology","volume":"9","author":"Watanabe","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.cellin.2024.100226_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi1145","article-title":"Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy","volume":"15","author":"Wellhausen","year":"2023","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100126","article-title":"Characterization of a thermostable Cas12a ortholog","volume":"2","author":"Wu","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib79","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2019.12.016","article-title":"Prime editing: Precision genome editing by reverse transcription","volume":"77","author":"Yan","year":"2020","journal-title":"Molecular Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100044","article-title":"Multi-color RNA imaging with CRISPR-Cas13b systems in living cells","volume":"1","author":"Yang","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib81","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2019.11.030","article-title":"One prime for all editing","volume":"179","author":"Yang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100042","article-title":"Signaling and functions of interleukin-33 in immune regulation and diseases","volume":"1","author":"Yi","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib83","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.stem.2024.10.009","article-title":"To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy","volume":"31","author":"Yin","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cellin.2024.100226_bib84","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","article-title":"A\u00a0safe and potent anti-CD19 CAR T cell therapy","volume":"25","author":"Ying","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2024.100226_bib85","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/jcp.30064","article-title":"CRISPR\/Cas gene therapy","volume":"236","author":"Zhang","year":"2021","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.cellin.2024.100226_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100153","article-title":"Role of tumor cell pyroptosis in anti-tumor immunotherapy","volume":"3","author":"Zhang","year":"2024","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad018","article-title":"Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes","volume":"15","author":"Zhang","year":"2023","journal-title":"Journal of Molecular Cell Biology"},{"key":"10.1016\/j.cellin.2024.100226_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2023.100080","article-title":"Cas12a-based one-pot SNP detection with high accuracy","volume":"2","author":"Zhang","year":"2023","journal-title":"Cell Insight"},{"key":"10.1016\/j.cellin.2024.100226_bib89","article-title":"Tracking-seq reveals the heterogeneity of off-target effects in CRISPR-Cas9-mediated genome editing","author":"Zhu","year":"2024","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.cellin.2024.100226_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.aav9973","article-title":"Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos","volume":"364","author":"Zuo","year":"2019","journal-title":"Science"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892724000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892724000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:26:53Z","timestamp":1762648013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892724000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2772892724000816"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2024.100226","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision epitope editing: A path to advanced immunotherapies","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2024.100226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100226"}}